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time-of-flight mass spectrometry (MALDI-TOF/
MS) serves as a rapid and accurate means
to determine masses of proteins independent
of their shapes or interactions with other
molecules. It provides one of the most funda-
mental characterizations of major plasma pro-
teins. Purified proteins in saline or serum
specimens were prepared for analysis by dilu-
tion, mixing with a solution of sinapinic acid,
and drying on a target plate. Specimens were
analyzed in a linear TOF mode with external
calibration. Analyses of 24 purified plasma
proteins showed predominance of singly
charged ions with lesser amounts of dimer 
and doubly charged monomer, and provided
measured masses for these proteins. A
number of proteins, including albumin, trans-
ferrin, apolipoproteins A-I, A-II, C-I, C-II, and
C-III, and prealbumin, could be analyzed
directly in serum with appropriate dilution.
Measured values for masses of major plasma
proteins will assist in analysis of serum and
plasma. It is possible to analyze a number of
components by MALDI-TOF/MS directly in
diluted serum. Extremely simple sample
preparation techniques may be useful in ana-
lyzing structural variation of several major
plasma proteins, particularly those with
masses <30 kDa, including a number of
apolipoproteins and markers of nutritional
status or acute phase responses.
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Introduction
Matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-
TOF/MS), invented in the late 1980s (1,2),
serves as a technique for analyzing peptides
and proteins in relatively complex samples. It
has even been employed for the direct analysis
of tissue specimens (3). In this technique, speci-
mens containing peptides and protein are dried
on a target plate together with a light-absorbing
matrix molecule. Vaporization of the mixture of
protein and matrix by a laser releases ionized
protein molecules, often with a single charge,
which can be analyzed in a TOF mass spec-
trometer. It serves as a simple and rapid analyt-
ical technique for determining the molecular
weights and heterogeneity of small amounts of
protein. In general, intact molecular ions are
formed from individual peptide chains, allow-
ing accurate determination of polypeptide mass
(4–6). However, there may be some technique-
dependent variation in measured mass related
to variable loss of labile groups, such as sialic
acids or association of sodium or matrix with
protein molecular ions (4–10).
Sample preparation is a key step in the
analysis of complex specimens by MALDI-
TOF/MS. Variables, such as protein con-
centration, salt concentration, or specimen
fractionation, may strongly influence the
observed spectra. Usual approaches for sample
preparation for MALDI-TOF/MS involve
desalting and cleanup of specimens by tech-
niques such as dialysis, solid-phase extrac-
tions, or fractionation through absorption to
a specialized target surface (in a variant of
MALDI-TOF/MS that has been termed sur-
face-enhanced laser desorption/ionization or
SELDI) or to magnetic beads (5–16). These
preparation steps involve significant time,
expense, and potential losses of selected com-
ponents. In the present study, we examined
direct analysis of serum and purified serum
components as a very simple approach that
might be applicable for routine in the clinical
laboratory and that would avoid modification
or selective losses of components during
preparation. 
Materials and Methods
Peptides and proteins used as calibrators and
sinapinic acid used as the specimen matrix were
purchased from Bruker Daltonics (Billerica,
MA). Masses of calibrators were: (bovine
insulin)+, 5734.61; (equine cytochrome c)+,
12,361.20; (equine myoglobin)+, 16,952.62;
(bovine serum albumin)2+, 33,216; (bovine
serum albumin)+, 66,431; (bovine serum albu-
min dimer)+, 132,859. Purified proteins were
obtained from the following sources: human
holo-transferrin, prealbumin, immunoglobulin
G (reagent grade), α1-antitrypsin, and α1-acid
glycoprotein, from Sigma Chemical (St. Louis,
MO); human haptoglobin (mixed types),
α2HS-glycoprotein, Gc globulin, α2-macroglob-
ulin, immunoglobulin A, neutrophil lysozyme,
and C-reactive protein from Calbiochem (La
Jolla, CA); β2-glycoprotein I, Glu-plasminogen,
and antithrombin III from Haematologic Tech-
nologies, Inc. (Essex Junction, VT). Lipopro-
teins including apolipoproteins A-I, A-II, C-I,
C-II, C-III, and E were purified by standard
published procedures (17). Purified proteins
were generally in stock solutions from 1 to
10 g/L in concentration. Serum specimens
were remnants of human specimens submitted
to the clinical laboratory used in accordance
with a protocol approved by an Institutional
Review Board.
Calculated masses of proteins were based
on amino acid sequences in well-validated
databases, usually the Swiss-Prot database
(www.ebi.ac.uk/swissprot). Calculations of
polypeptide masses were performed with
software offered by the National Institute
of Diabetes and Digestive and Kidney Dis-
eases mass spectrometry group (sx.102a.
niddk.nih.gov/peptide). Calculated peptide
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masses did not include the masses of
oligosaccharide components.
Analyses were performed with an Ultraflex
TOF mass spectrometer (Bruker Daltonics) in a
linear positive ion mode similar to previously
described analyses (12). Specimens were
analyzed with two programs of separation
parameters. To examine an m/z range of
5000 to 30,000, pulsed extraction had a delay
of 300 ns. To examine m/z > 30,000, there was
a delay of 550 ns. Specimens were prepared by
dilution with 10 mmol/L ammonium acetate
and then by mixing 1 vol of diluted specimen
with 2 vol of matrix solution containing 10 g/L
sinapinic acid in 40% acetonitrile/10%
ethanol/50% water containing 0.1% trifluo-
roacetic acid. Specimens were applied twice to
a 384-position sample plate as 1-µL aliquots
and allowed to air-dry. Specimens were ana-
lyzed with manual laser positioning and
adjustment of laser power. All figures shown
represent data collected from 10 positions,
summing a total of 300 laser pulses. Measure-
ments of m/z were performed using external
calibration. Masses of proteins were measured
at the peak apex.
Results
Most serum proteins are globulins that
require the presence of some salt to maintain
solubility, but salts tend to suppress ionization
of proteins in MALDI-TOF/MS. Therefore,
there is a compromise between physiological
salt conditions that maintain protein solubility
and the efficiency of ionization. We examined
the ability to analyze purified proteins in
saline solutions by MALDI-TOF/MS, using
simple dilution of the proteins with matrix
solution. Generally, these analyses yielded a
pattern in which the singly charged molecular
ion predominated, but lesser amounts of
dimer, trimer, or doubly charged monomer
often were observed, as shown for the exam-
ples of α1-acid glycoprotein, transferrin, and
immunoglobulin G as shown in Fig. 1 panels
A–C, respectively, or for apolipoprotein A-I
and transthyretin in Fig. 2. These analyses
served as a relatively rapid method to deter-
mine the mass of specific components and to
evaluate the tendency to form dimers and
multiply charged ions. 
Table 1 lists the measured masses of 23
plasma proteins that were available as puri-
fied components, plus serum amyloid A,
which was observed in serum from a patient
with an acute phase response as characterized
in other studies (18). The broader peaks of
high molecular weight proteins, probably
reflecting both lower resolution and increased
microheterogeneity from variable glycosyla-
tion, led to greater imprecision in the mea-
surement of masses for these components.
Comparison of measured values in Table 1 vs
older published values based on techniques
such as compositional analysis, electrophoresis,
and ultracentrifugation generally showed
fairly good agreement for proteins lacking
oligosaccharides. MALDI-TOF/MS provided
lower estimates of masses for most glycopro-
teins than the classical textbook values. Mea-
sured values for several proteins with high
carbohydrate content such as α1-acid glyco-
protein, antithrombin III, α2-HS-glycoprotein,
and α1-antichymotrypsin were more than 10%
lower than older published values. Measured
values for glycoprotein I and plasminogen
were about 10% higher than published values. 
MALDI-TOF/MS should provide highly
accurate of proteins without posttransla-
tional modifications, and, in most cases,
there is good agreement for these proteins
with calculated masses based on amino acid
sequence databases. For proteins bearing com-
plex oligosaccharides and other substantial
posttranslational modifications, the sequence
databases are not very useful for estimating
masses. Values measured by MALDI-TOF/MS
should represent accurate estimates with the
caveat that there may be some underestima-
tion of mass as a result of loss of some groups
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Fig. 1. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of α1-acid glycoprotein (A),
transferrin (B), and immunoglobulin G (C).
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such as sialic acids during desorption and ion-
ization (6–10). Losses of sialic acid may vary
depending on technique of analysis, leading
to differences in measured mass; as an exam-
ple, measurements of the mass of α1-acid
glycoprotein by MALDI-TOF/MS vary from
about 32,000 to 36,000 in different studies
(5,9,21). In general, the ionization efficiency
appeared to be poorer for high molecular
weight and highly glycosylated components.
Haptoglobin and α2-macroglobulin were not
included in Table 1 as they yielded very weak
and diffuse peaks at m/z of about 96,000 and
124,000 for haptoglobin (mixed types) and
178,000 for α2-macroglobulin. 
Serum required an initial dilution by a factor
of about fivefold with aqueous diluent before
further threefold dilution with matrix to obtain
any detectable spectra. The high protein con-
tent of serum probably did not allow a high
enough ratio of matrix to protein to provide
for efficient ionization of undiluted specimens.
Matrix usually needs to be in more than
1000-fold molar excess relative to protein to
yield good spectra (6). Several diluents were
examined such as 10 mM ammonium acetate,
10 mM ammonium bicarbonate, normal
saline, and other solutions with varying ionic
strength. Diluents with an ionic strength above
that of normal saline suppressed ionization.
The solutions of 10 mM ammonium acetate
and 10 mM ammonium bicarbonate were sub-
jectively considered to yield similar results
with greatest peak intensities (not shown). A
solution of 10 mM ammonium acetate was
used as diluent for subsequent experiments
described here. Dilution of serum with 19 vol
of 10 mM ammonium acetate plus 40 vol of
matrix solution yielded spectra as shown in
Fig. 3. In the top panel, the m/z range from
5000 to 30,000 is shown and, in the bottom
panel, m/z from 30,000 to 100,000 is shown.
For m/z > 30,000, singly and doubly charged
albumin is the dominant component. A peak
corresponding to expected position of transfer-
rin generally was visible and a number of
other minor unidentified peaks were observed.
If the analysis was extended beyond m/z of
150,000, peaks were observed in the expected
positions for albumin dimer and IgG. In the
m/z range from 5000 to 30,000, there were a
number of sharper peaks, corresponding to the
expected positions of apolipoproteins A-I, A-II,
C-I, C-II, C-III, and transthyretin. Although
some of these proteins, such as apolipoprotein
C-I, C-II, and C-III, are often considered
relatively minor serum components, they are
among the 20 most abundant components on a
molar basis (20). In general, ion intensities
for individual proteins in MALDI-TOF/MS
should relate to the molar concentration of a
protein, and there is a strong bias for detection
of low molecular weight proteins (20,21).
Fig. 2. Matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry of apolipoprotein 
A-I (Top) and transthyretin also known as pre-
albumin (Bottom).
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A peak corresponding to the expected position
(m/z = 6630) of apolipoprotein C-I was one of
the strongest peaks, suggesting unusually effi-
cient ionization of this protein, whereas the 
ionization of apolipoprotein A-II appeared
relatively inefficient considering its higher
abundance relative to apolipoproteins C-I, C-II,
and C-III. Different peptides and proteins are
recognized to have highly variable ionization
in MALDI-TOF/MS with content of arginine
residues a significant factor in ionization of
peptides (22). Although there are reported to
be a large number of small peptide compo-
nents in serum (23–26), components with
m/z < 5000 were not observed clearly under
the conditions of analysis used here and this
region of the spectrum is not shown. Detection
of small peptides probably is suppressed
owing to their much lower abundance relative
to proteins.
Most peaks in the spectra appeared to
decrease in signal intensity with increasing
dilution with 10 mM ammonium acetate as
shown in Fig. 4 (prior to further threefold
dilution with matrix solution). Most compo-
nents had decreasing intensities for dilutions
from about 10- to 300-fold; however, peaks
related to albumin increased in intensity over
this range of dilutions and began to decrease
in intensity only at dilutions more than 100-
fold. Apparently the concentrations of albumin
were saturating at low dilutions. Absolute
Fig. 3. Matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry of diluted serum.
(Top) m/z range from 5000 to 30,000 with tentative
identification of major peaks. (Bottom) m/z range
from 30,000 to 100,000.
Fig. 4. Peak intensities (peak heights) with varying
dilution of serum. Listed dilutions reflect dilution with
10 mM ammonium acetate prior to further three-
fold dilution with matrix solution.
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intensities of signals in MALDI-TOF/MS usu-
ally are subject to substantial variation from
one laser shot to the next. The fairly dense
application of matrix with serum in this study,
however, yielded fairly consistent signals, and
variation was reduced somewhat by summing
signals from 300 laser shots for each analysis.
Because peaks were compared within the
same analysis, other peaks within an analysis
served as controls for consistency of the results.
Comparison of peak ratios between compo-
nents might be considered a more valid
approach for this analytical technique, but it
leads to similar results. These dilution studies
led to a conclusion that there was an optimal
dilution for analysis of most components other
than albumin that was about a 10- or 20-fold
dilution with ammonium acetate prior to
further dilution with matrix. 
The measured m/z for a number of peaks
in serum samples appeared to correspond to
the expected values for several major serum
components. Data for repeated analysis of two
specimens are shown in Table 2. Most peaks
corresponded to expected values within the
precision of measurement. An exception was
transthyretin, which is known to be polymor-
phic and to undergo a variety of modifications
that may affect it mass (27,28). The mass mea-
surements indicated that it was possible to
obtain accurate mass measurements of several
of the most abundant components in the com-
plex mixture of serum proteins without exten-
sive fractionation or removal of salts. For the
smaller proteins, the pairing of sodium ions or
matrix molecules with the protein would have
been apparent in mass measurements.
Discussion
Significant information about molecular
masses and heterogeneity of concentrated
solutions of purified proteins or even the
complex mixture represented by serum was
obtained by MALDI-TOF/MS simply by
Table 2
Major Peaks in MALDI-TOF Mass Spectrometric Analysis 
of Two Serum Specimens and Tentative Assignmentsa
Measured m/z Assignment Expected mass
High m/z region (>30,000)
147,860 ± 490/147,170 ± 700 [IgG + H]+ ~148,000
133,320 ± 410/132,960 ± 270 [Albumin2 + H]+ 132,855
79,180 ± 240/79,360 ± 310 [Transferrin + H]+ 79,110
66,540 ± 90/66,550 ± 140 [Albumin + H]+ 66,428
33,290 ± 130/33,240 ± 170 [Albumin + 2H]+2 33,216
Low m/z region (5000–30,000)
28,015 ± 15/28,038 ± 12 [Apo A-I + H]+ 28,078
13,876 ± 2/13,868 ± 1 [Prealbumin + Cys + H] 13,946
13,756 ± 2/13,747 ± 2 [Prealbumin + H]+ 13,827
9424 ± 1/9417 ± 3 [Apo C-III1 + H]+ 9422.3
8914 ± 1/8911 ± 1 [Apo C-II + H]+ 8917
8809 ± 1/8806 ± 1 [Apo A-II + Cys + H]+ 8811
8686 ± 3/8680 ± 1 [Apo A-II (monomer) + H]+ 8692
6630 ± 1/6631 ± 1 [Apo C-I + H]+ 6631
6433 ± 1/6432 ± 1 [Apo C-I (–ThrPro-) + H]+ 6433
aValues for m/z are means ± SD of six measurements.
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dilution of specimens together with matrix
and drying on a target plate. Measured mass
values in Table 1 serve as a database for the
expected positions of peaks for a number 
of serum components when analyzed by
MALDI-TOF/MS. These data may be of value
in helping to identify which proteins are form-
ing peaks and in identifying peaks that may
be useful for internal calibration of masses
during an analyses. Of course, masses of some
proteins may vary owing to sequence poly-
morphism, variable posttranslational modifi-
cation, or degradation during processing or
storage. Measured masses of highly sialylated
proteins by MALDI-TOF/MS also may vary
depending on several variables, as previously
noted. Also, it must be considered that there
is structural variation in glycosylation of pro-
teins in different physiological states that may
lead to changes in glycoprotein mass (27,28).
Direct analysis of diluted serum specimens
by MALDI-TOF/MS may offer a rapid and
inexpensive approach to analyze several major
serum components with minimal opportunities
for modification or selective loss of compo-
nents. For proteins lacking labile posttransla-
tional modifications, the mass measurements
determined by MALDI-TOF/MS should be
accurate measures of protein mass. For several
of the most abundant proteins with masses less
than 30,000, mass measurements can be made
with sufficient precision and accuracy to allow
detection of most chemical modifications of
proteins or sequence polymorphisms.
Two drawbacks of the analysis of a complex
mixture, such as serum, without fractionation
are the detection of only a few of the most
abundant components and the general sup-
pression of signals by the high protein and salt
concentrations. Dominance of the albumin
peaks for monomer, doubly charged monomer,
and singly charged monomer interfere with
the ability to detect other peaks with m/z >
30,000. Selective immunodepletion of albumin
or albumin plus immunoglobulin G may be
helpful in examining other protein compo-
nents in this region. This may be a practical
procedure considering that less than 1 µL of
serum is required per analysis. For ions with
m/z < 30,000, only several of the most abun-
dant components are observed. Specimen frac-
tionation would be required to see lower
abundance components. Consequences of the
general suppression of ionization by other
ions and proteins are relatively weak signals,
detection only of high abundance compoents,
and the need to spend more time with data
acquisition to sum data from a large number
of laser shots. Use of relatively high laser
power may be necessary to obtain measurable
peaks, and this may lower resolution and pro-
mote fragmentation of proteins. Low peak
intensities and resolution also can be a limit-
ing factor in obtaining precise and accurate
mass measurements. 
The method of sample preparation
described here offers a simple approach to
analyze a number of major serum compo-
nents. In particular, it appears best suited to
analyze components with a mass less than
30,000 where there is better sensitivity, resolu-
tion, and less interference from albumin. This
technique would be useful for identifying
polymorphisms or modifications of compo-
nents, such as by cysteinylation in the exam-
ple of transthyretin (29,30). A significant
portion of apolipoprotein A-I, appeared as a
hump following the major expected peak, sug-
gesting a modification increasing its mass by
about 150 Da, which merits further investiga-
tion; this protein may undergo fatty acylation
and is susceptible to nitration and chlorination
(31,32). Alternatively, this may represent adduct
formation with a matrix molecule (6). Variants
of a number of other apolipoproteins have
been described including a truncated form of
apolipoprotein C-I, which has lost two amino
acids from its N-terminus (33,34). The latter
truncated form of apolipoprotein C-I was
observed consistently in our analyses.
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In conclusion, considerable information
about structural variation of small apopli-
poproteins and prealbumin may be obtained
by the simple technique described here. It
would offer applications similar to the 
previously described characterization of
hemoglobin variants by simple dilution of
extracts from dried blood spots (35). As pre-
sented here, the analysis is primarily qualita-
tive in nature. Any effort to apply this a
quantitative technique for profiling the relative
amounts of different proteins would require
extensive investigation of appropriate dilu-
tions, the linearity, and calibration of
responses, and standardization of procedures.
Qualitative analysis of the global pattern of
most abundant proteins may have value for a
number of purposes. It may assist in interpret-
ing the degree of fractionation achieved by
other techniques such as SELDI-TOF/MS. The
major components observed here are likely to
show up frequently as peaks during SELDI-
TOF/MS analysis (18). During the acute phase
response, other components, such as serum
amyloid A and C-reactive protein, become sub-
stantially elevated so that they also may
observed (18,20,36,37). The simple “dilute and
shoot” approach for MALDI-TOF/MS analysis
of serum or plasma may be of greatest value
in identifying qualitative changes of proteins,
such as provided by the previously listed
examples. This approach may be of value for
clinical applications owing to its simplicity.
Some protein variants may be indicators of risk
for amyloidosis, cardiovascular disease, or of
inflammatory responses. Although there is
great interest in trying to apply MALDI-TOF
or SELDI-TOF/MS for the analysis of low
abundance serum and plasma components, the
most abundant components in serum or
plasma tend to dominate observed spectra
unless there is extensive effort at specimen
fractionation (20). The present report considers
that there is potentially valuable information
to be gained from analysis of several of 
the most abundant components that tend to
dominate analyses of unfractionated serum or
plasma, just as important clinical information
is provided by routine clinical laboratory quan-
titative or qualitative analysis of major compo-
nents such as albumin, immunoglobulins,
transferrin, and apolipoproteins.
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